ArrowMark Colorado Holdings LLC Boosts Holdings in Phreesia, Inc. (NYSE:PHR)

ArrowMark Colorado Holdings LLC grew its stake in Phreesia, Inc. (NYSE:PHR - Free Report) by 41.2% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 484,617 shares of the company's stock after purchasing an additional 141,411 shares during the quarter. ArrowMark Colorado Holdings LLC owned about 0.83% of Phreesia worth $12,193,000 at the end of the most recent reporting period.

A number of other institutional investors have also made changes to their positions in PHR. Johnson Financial Group Inc. increased its stake in shares of Phreesia by 381.3% during the 4th quarter. Johnson Financial Group Inc. now owns 1,131 shares of the company's stock worth $28,000 after purchasing an additional 896 shares during the last quarter. R Squared Ltd bought a new stake in shares of Phreesia during the fourth quarter worth approximately $30,000. BankPlus Trust Department acquired a new position in shares of Phreesia in the fourth quarter valued at approximately $34,000. Quarry LP increased its stake in shares of Phreesia by 210.9% during the fourth quarter. Quarry LP now owns 2,835 shares of the company's stock worth $71,000 after purchasing an additional 1,923 shares during the period. Finally, Venturi Wealth Management LLC acquired a new stake in Phreesia during the 4th quarter worth approximately $76,000. 92.10% of the stock is owned by institutional investors and hedge funds.

Insider Activity at Phreesia

In other news, General Counsel Allison C. Hoffman sold 1,213 shares of the company's stock in a transaction dated Wednesday, April 16th. The shares were sold at an average price of $23.81, for a total value of $28,881.53. Following the sale, the general counsel now directly owns 137,921 shares of the company's stock, valued at $3,283,899.01. This represents a 0.87 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, SVP David Linetsky sold 4,499 shares of Phreesia stock in a transaction dated Wednesday, April 16th. The shares were sold at an average price of $23.73, for a total transaction of $106,761.27. Following the transaction, the senior vice president now directly owns 217,239 shares of the company's stock, valued at approximately $5,155,081.47. This trade represents a 2.03 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 111,940 shares of company stock worth $3,103,023 over the last quarter. 5.80% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

A number of research firms have recently weighed in on PHR. Needham & Company LLC reissued a "buy" rating and set a $29.00 target price on shares of Phreesia in a report on Thursday, March 13th. DA Davidson dropped their price objective on Phreesia from $36.00 to $34.00 and set a "buy" rating for the company in a report on Monday, April 14th. Canaccord Genuity Group raised their price target on Phreesia from $34.00 to $35.00 and gave the stock a "buy" rating in a research report on Thursday, March 13th. Piper Sandler reiterated an "overweight" rating and set a $33.00 price objective (up from $31.00) on shares of Phreesia in a research note on Wednesday, January 29th. Finally, Citigroup boosted their price objective on shares of Phreesia from $31.00 to $35.00 and gave the company a "buy" rating in a research report on Friday, January 10th. Twelve analysts have rated the stock with a buy rating, According to data from MarketBeat.com, the company has a consensus rating of "Buy" and a consensus price target of $31.33.

Phreesia Trading Up 0.5 %

Shares of Phreesia stock traded up $0.13 during trading on Wednesday, reaching $24.39. 507,501 shares of the stock were exchanged, compared to its average volume of 431,778. Phreesia, Inc. has a 1 year low of $17.07 and a 1 year high of $30.53. The firm has a market cap of $1.43 billion, a price-to-earnings ratio of -16.59 and a beta of 0.74. The company has a quick ratio of 1.74, a current ratio of 1.74 and a debt-to-equity ratio of 0.04. The stock's fifty day moving average is $25.13 and its 200 day moving average is $24.60.

Phreesia Company Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.